News
Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug ...
Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...
You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and ...
The Department of Justice has reached a proposed settlement with UnitedHealth Group and Amedisys regarding UnitedHealth’s ...
The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...
A judge recently blocked an Arkansas law that would have banned PBMs from owning and operating pharmacies in the state.
The deal helps move BioNTech’s proposed acquisition of CureVac closer to completion. With the settlement, GSK said it will tender the CureVac shares it owns in support of the $1.25 billion acquisition ...
Medical coding startup Arintra raised $21 million in Series A funding to help hospitals and physician groups secure accurate, timely reimbursement. The company’s AI-powered platform automates ...
Response Pharmaceuticals takes a new approach to weight loss with an oral small molecule designed to inhibit a protein called iMTP to reduce uptake of fats and cholesterol. While this drug’s ...
Isaac Health, a startup specializing in cognitive care for Alzheimer’s dementia , raised $10.5 million in Series A funding to expand nationwide access to its platform. The company partners with ...
RFK Jr. Cancels $500M in mRNA R&D Contracts as HHS Turns Focus to Older, Slower Vaccine Technologies
Health and Human Services Secretary Robert F. Kennedy Jr. is cancelling 22 mRNA vaccine contracts funded by BARDA. Without evidence, Kennedy claimed these vaccines fail to protect effectively against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results